LABORATORY RESEARCH Targeting Cancer Stem Cell in Castration Resistant Prostate Cancer The authors demonstrated that immortalized normal human prostate epithelial cells, which appeared non-tumorigenic in vivo, become tumorigenic and acquire stem cell phenotype after knocking down a tumor suppressor gene. [Clin Cancer Res] Abstract NFATc1 Promotes Prostate Tumorigenesis and Overcomes PTEN Loss-Induced Senescence Researchers found the upregulation of nuclear factor of activated T cells c1 (NFATc1) in human prostate cancer (PCa) and cultured PCa cells, but not in normal prostates and non-tumorigenic prostate cells. [Oncogene] Abstract Glucocorticoid Receptor Antagonism Reverts Docetaxel-Resistance in Human Prostate Cancer The authors studied the role of the glucocorticoid receptor (GR) in docetaxel-resistant prostate cancer in order to improve current prostate cancer therapies. GR expression was analyzed in a tissue microarray of primary prostate cancer specimens from chemo-naïve and docetaxel-treated patients, and in cultured prostate cancer cell lines with acquired docetaxel-resistance. [Endocr Relat Cancer] Abstract Estrogen Exhibits a Biphasic Effect on Prostate Tumor Growth through the ERβ-KLF5 Pathway Scientists demonstrated that estrogen (E2) has biphasic effects on prostate tumor growth. A lower dose of E2 increased tumor growth in mouse xenograft models using DU145 and PC-3 human prostate cancer cells, whereas a higher dose significantly decreased tumor growth. [Mol Cell Biol] Abstract Enhanced G2/M Arrest, Caspase Related Apoptosis and Reduced E-Cadherin Dependent Intercellular Adhesion by Trabectedin in Prostate Cancer Stem Cells Investigators studied the effect of trabectedin in cell proliferation, cell cycle progression, apoptosis and spheroid formation in prostate cancer stem cells. [PLoS One] Full Article Celastrol Induces Autophagy by Targeting AR/miR-101 in Prostate Cancer Cells The authors found that androgen receptor (AR) played a negative role in AR degrader celastrol-induced autophagy. Knockdown of AR in AR-positive prostate cancer cells resulted in enhanced autophagy. [PLoS One] Full Article Inhibition of Fatty Acid Synthase Sensitizes Prostate Cancer Cells to Radiotherapy Researchers examined the potential of fatty acid synthase inhibition to sensitize prostate cancer cells to radiotherapy. The efficacy of C75 alone or in combination with X irradiation was examined in monolayers and in multicellular tumor spheroids. [Radiat Res] Abstract Krüppel-Like Factor 5 Promotes Apoptosis Triggered by Tumor Necrosis Factor α in LNCaP Prostate Cancer Cells via Up-Regulation of Mitogen-Activated Protein Kinase Kinase 7 Scientists identified how Krüppel-like factor 5 and tumor necrosis factor α pathway, which can induce apoptosis in cancer, regulate each other in LNCaP prostate cancer cells. [Urol Oncol] Abstract CLINICAL RESEARCH Pharmacokinetics, Antitumor Activity, and Safety of ODM-201 in Patients with Chemotherapy-Naive Metastatic Castration-Resistant Prostate Cancer: An Open-Label Phase I Study Researchers evaluated the pharmacokinetics of ODM-201 tablet products and preliminary long-term safety, tolerability, and antitumor activity of ODM-201 in chemotherapy-naive men with metastatic castration-resistant prostate cancer. [Eur Urol] Abstract Efficacy and Safety of Leuprorelin Acetate 6-Month Depot in Prostate Cancer Patients: A Phase III, Randomized, Open-Label, Parallel-Group, Comparative Study in Japan Investigators assess the non-inferiority of a six-month depot formulation of TAP-144-SR 22.5 mg to a three-month depot formulation of TAP-144-SR 11.25 mg in prostate cancer patients in Japan. [Jpn J Clin Oncol] Abstract |